BSEKabra Drugs LtdMediumNeutral
Announced Fri, 30 May · 20:11 IST

Appointment of Secretatial Auditor

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kabra Drugs Ltd has appointed Anshu Chouhan & Associates, Practicing Company Secretaries, as the Secretarial Auditor of the company for the financial year 2024-25. The appointment was made on May 30, 2025, to comply with the Companies Act, 2013 and SEBI Listing Regulations. The appointed firm is led by CS Anshu Chouhan and has over 8 years of experience in secretarial audits, statutory compliance, and SEBI/FEMA/RBI matters. No relationship between the auditor and the company's directors has been disclosed.

Likely market impact

This is a routine regulatory compliance appointment and is unlikely to have any material impact on shareholders or the stock price. It does not signal any governance concerns or changes in leadership.